ASCVD
Clinical trials for ASCVD explained in plain language.
Never miss a new study
Get alerted when new ASCVD trials appear
Sign up with your email to follow new studies for ASCVD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Which diabetes drug best protects your heart? 60,000-person study aims to find out.
Disease control OngoingThis large study looks at real-world data from 60,000 people with type 2 diabetes and obesity to compare four diabetes drugs—dulaglutide, semaglutide, tirzepatide, and sitagliptin—in preventing heart attacks, strokes, and death. Researchers are analyzing insurance claims to see w…
Matched conditions: ASCVD
Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New study aims to boost cholesterol treatment in heart disease patients
Disease control ENROLLING_BY_INVITATIONThis study looks at different methods to help patients with high cholesterol and heart disease get the right medicines to lower their cholesterol. About 300 adults at high risk will take part. The goal is to see which approach helps more people reach their target LDL cholesterol …
Matched conditions: ASCVD
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Computer alert aims to boost cholesterol treatment in heart patients
Disease control OngoingThis study tests whether an electronic alert in the medical record can help doctors prescribe better cholesterol-lowering medications for heart disease patients with high LDL. About 400 patients from a single hospital will be randomly assigned to have their doctor receive the ale…
Matched conditions: ASCVD
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Can a gentler cholesterol combo prevent diabetes in heart patients?
Disease control ENROLLING_BY_INVITATIONThis study looks at 4,000 adults with prediabetes and heart disease to see if a low-intensity statin combined with ezetimibe is better than a high-intensity statin alone at preventing new diabetes. Participants will be followed to track diabetes development and heart health. The …
Matched conditions: ASCVD
Phase: PHASE4 • Sponsor: Seung-Whan Lee, M.D., Ph.D. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC